Ancora Pharmaceuticals - Carbohydrate Synthesis Technology Platform's Unit Acquisition

Ancora Pharmaceuticals - Carbohydrate Synthesis Technology Platform raised a round of funding on November 07, 2013. Investors include CordenPharma International.

Ancora Pharmaceuticals aims to enable synthetic carbohydrate-based product discovery and development utilizing its carbohydrate synthesis capability, which is based on technology originally developed …

Articles about Ancora Pharmaceuticals - Carbohydrate Synthesis Technology Platform's Unit Acquisition: